Application of key events analysis to chemical carcinogens and noncarcinogens.
The existence of thresholds for toxicants is a matter of debate in chemical risk assessment and regulation. Current risk assessment methods are based on the assumption that, in the absence of sufficient data, carcinogenesis does not have a threshold, while noncarcinogenic endpoints are assumed to be thresholded. Advances in our fundamental understanding of the events that underlie toxicity are providing opportunities to address these assumptions about thresholds. A key events dose-response analytic framework was used to evaluate three aspects of toxicity. The first section illustrates how a fundamental understanding of the mode of action for the hepatic toxicity and the hepatocarcinogenicity of chloroform in rodents can replace the assumption of low-dose linearity. The second section describes how advances in our understanding of the molecular aspects of carcinogenesis allow us to consider the critical steps in genotoxic carcinogenesis in a key events framework. The third section deals with the case of endocrine disrupters, where the most significant question regarding thresholds is the possible additivity to an endogenous background of hormonal activity. Each of the examples suggests that current assumptions about thresholds can be refined. Understanding inter-individual variability in the events involved in toxicological effects may enable a true population threshold(s) to be identified.
Boobis
Alan R
AR
Department of Experimental Medicine and Toxicology, Imperial College London, London W12 0NN, UK.
Daston
George P
GP
Preston
R Julian
RJ
Olin
Stephen S
SS
D000465:Algorithms; D002273:Carcinogens / Q000493:pharmacokinetics* / Q000633:toxicity*; D004249:DNA Damage; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D052244:Endocrine Disruptors / Q000493:pharmacokinetics / Q000633:toxicity; D005506:Food Contamination; D011634:Public Health; D018570:Risk Assessment; D012959:Socioeconomic Factors
D002273:Carcinogens; D052244:Endocrine Disruptors
Nature. 2007 Mar 8;446(7132):153-8
17344846
Toxicol Appl Pharmacol. 1984 May;73(3):511-24
6719466
Cell. 1990 Jun 1;61(5):759-67
2188735
Toxicol Appl Pharmacol. 2006 Jun 15;213(3):267-81
16630638
Toxicology. 2002 Dec 27;181-182:115-20
12505295
Biol Pharm Bull. 2005 Jul;28(7):1221-3
15997102
Lab Invest. 1967 Apr;16(4):591-603
4290484
Risk Anal. 1994 Jun;14(3):333-8
7518093
Risk Anal. 2007 Dec;27(6):1535-51
18093051
Fed Regist. 1985 Dec 4;50(233):49760-2
11645578
Mutat Res. 1999 Mar 8;424(1-2):237-47
10064864
Arch Toxicol. 2006 Dec;80(12):797-803
16710696
Environ Health Perspect. 2004 Nov;112(16):1589-606
15598610
Drug Metab Dispos. 2004 Jul;32(7):727-33
15205388
Food Chem Toxicol. 2006 Oct;44(10):1636-50
16891049
J Proteome Res. 2008 Feb;7(2):497-503
18179164
J Toxicol Environ Health A. 2004 Apr 9;67(7):537-53
15129551
Mutagenesis. 2006 May;21(3):173-8
16613912
Int J Toxicol. 2003 Jan-Feb;22(1):25-33
12573946
Drug Metab Dispos. 1981 Jul-Aug;9(4):334-9
6114833
Toxicol Appl Pharmacol. 1983 Sep 30;70(3):480-5
6636176
Toxicology. 2004 May 20;198(1-3):239-48
15138047
Toxicol Appl Pharmacol. 1998 Apr;149(2):217-25
9571991
Crit Rev Toxicol. 2003;33(6):591-653
14727733
Biochem Pharmacol. 1998 Aug 1;56(3):377-87
9744576
Toxicol Lett. 2005 Nov 15;159(2):182-91
15994032
Toxicol Sci. 1998 Nov;46(1):61-74
9928669
PLoS One. 2009;4(2):e4584
19240792
J Biochem. 1991 Oct;110(4):559-65
1778977
J Appl Toxicol. 2004 May-Jun;24(3):203-10
15211614
Annu Rev Genomics Hum Genet. 2008;9:387-402
18576944
Toxicol Ind Health. 1999 Jan-Mar;15(1-2):48-64
10188191
Toxicol Sci. 2008 Dec;106(2):312-8
18791183
Arch Toxicol. 1997;71(10):638-45
9332701
Toxicology. 2003 May 3;187(2-3):101-15
12699900
Biochim Biophys Acta. 2006 May-Jun;1757(5-6):509-17
16829228
J Toxicol Environ Health A. 2007 Nov;70(22):1936-45
17966065
Mol Pharmacol. 1997 Mar;51(3):370-6
9058590
Toxicol Sci. 2005 Aug;86(2):396-416
15901920
Mt Sinai J Med. 2006 Jul;73(4):657-72
16878272
J Pharmacol Exp Ther. 2003 Oct;307(1):402-7
14500779
Environ Health Perspect. 1986 Nov;69:301-5
3816733
Cancer Lett. 1996 Jun 24;104(1):71-8
8640749
Toxicol Appl Pharmacol. 1983 Sep 30;70(3):467-79
6636175
Environ Health Perspect. 2009 Feb;117(2):283-7
19270800
Cell Biochem Biophys. 2009;53(1):17-31
19034694
Hum Exp Toxicol. 2001 Jul;20(7):321-7
11530830
Biochem Pharmacol. 1997 Mar 21;53(6):765-71
9113097
Chem Biol Interact. 1981 Oct;37(1-2):207-17
7285244
Fundam Appl Toxicol. 1996 Jul;32(1):109-25
8812246
Toxicol Appl Pharmacol. 1984 Jan;72(1):159-68
6143425
Physiol Genomics. 2003 Oct 17;15(2):127-41
12915738
Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):89-104
14574440
Novartis Found Symp. 2007;282:3-25; discussion 25-8, 212-8
17913221
Biochem Pharmacol. 1987 Apr 1;36(7):1041-52
3566800
Environ Res. 2006 Jan;100(1):93-9
16256101
Toxicol Sci. 2007 Jun;97(2):467-90
17351261
Methods Mol Biol. 2006;316:35-48
16671399
Toxicol Appl Pharmacol. 1999 Oct 15;160(2):120-6
10527910
Regul Toxicol Pharmacol. 2001 Oct;34(2):146-52
11603957
Annu Rev Genet. 2004;38:445-76
15568983
Biochem Biophys Res Commun. 1988 Nov 30;157(1):55-60
2904264
Carcinogenesis. 1998 Jan;19(1):187-93
9472711
J Appl Toxicol. 2005 Jul-Aug;25(4):310-7
16025433
Biochem Biophys Res Commun. 1977 Dec 7;79(3):684-91
597296
Toxicol Sci. 2004 Jul;80(1):193-202
15084756
Chem Res Toxicol. 2008 Jan;21(1):253-65
18161944
Cell. 2000 Jan 7;100(1):57-70
10647931
Crit Rev Toxicol. 2008;38(2):87-96
18259981
Toxicol Appl Pharmacol. 1985 Jun 15;79(1):166-74
4049404
Toxicol Sci. 2000 Dec;58(2):366-76
11099648
Crit Rev Food Sci Nutr. 2009 Sep;49(8):682-9
19690994
Life Sci. 1978 Sep 11;23(10):1067-72
713686
Nature. 2009 Jan 1;457(7225):36-7
19122629
Crit Rev Toxicol. 2006 Nov-Dec;36(10):781-92
17118728
Drug Metab Dispos. 1984 May-Jun;12(3):304-8
6145557
Cancer Res. 2007 Apr 15;67(8):3904-11
17440105
Toxicol Appl Pharmacol. 1986 Apr;83(2):294-314
3961817
Hepatology. 1989 Oct;10(4):437-46
2673969
Fundam Appl Toxicol. 1994 Jan;22(1):90-102
8125218
Crit Rev Toxicol. 2005 Oct-Nov;35(8-9):673-83
16417034
Biochem Pharmacol. 1992 Apr 15;43(8):1876-9
1575782
Environ Health Perspect. 2005 Sep;113(9):1164-71
16140622
Eur J Cancer. 2008 Dec;44(18):2737-41
18977654